Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88079656 |
LAW OFFICE ASSIGNED |
LAW OFFICE 109 |
MARK SECTION |
MARK |
FULIVIO (see, http://uspto.report/TM/88079656/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
FULIVIO |
OWNER SECTION (current) |
NAME |
JOHNSON & JOHNSON |
MAILING ADDRESS |
One Johnson & Johnson Plaza |
CITY |
New Brunswick |
STATE |
New Jersey |
ZIP/POSTAL CODE |
08933 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
JOHNSON & JOHNSON |
MAILING ADDRESS |
One Johnson & Johnson Plaza |
CITY |
New Brunswick |
STATE |
New Jersey |
ZIP/POSTAL CODE |
08933 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
MATTHEW PATER |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmus@its.jnj.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
kmanchen@its.jnj.com |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and
pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases,
oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
03/12/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/mapjnj/ |
SIGNATORY'S NAME |
Matthew Pater |
SIGNATORY'S POSITION |
Attorney of Record |
DATE SIGNED |
02/21/2020 |
SIGNATORY'S PHONE NUMBER |
732-524-2826 |
FILING INFORMATION |
SUBMIT DATE |
Fri Feb 21 15:13:01 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XX.X.XX-202
00221151301951298-8807965
6-7107ad8b58cfac95891ec47
ea5a4e26a91328f1415b2b342
27a4c59b069a5723c6b-DA-13
011454-202002211139548447
28 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: FULIVIO (see, http://uspto.report/TM/88079656/mark.png)
SERIAL NUMBER: 88079656
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: JOHNSON & JOHNSON, having an address of
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States
Proposed: JOHNSON & JOHNSON, having an address of
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 03/12/2019.
For International Class 005:
Current identification: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central
nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases,
ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /mapjnj/ Date Signed: 02/21/2020
Signatory's Name: Matthew Pater
Signatory's Position: Attorney of Record
Signatory's Phone: 732-524-2826
RAM Sale Number: 88079656
RAM Accounting Date: 02/21/2020
Serial Number: 88079656
Internet Transmission Date: Fri Feb 21 15:13:01 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XX.X.XX-202002211513019512
98-88079656-7107ad8b58cfac95891ec47ea5a4
e26a91328f1415b2b34227a4c59b069a5723c6b-
DA-13011454-20200221113954844728